ABSTRACT BACKGROUND
INTRODUCTION
proposed as the causative factor, some studies report presence of insulin resistance and hyperinsulinemia.
Evidence of insulin resistance has also been noted in thalassemics without any abnormality in serum glucose. 4 In India and Nepal, chelation is suboptimal in most of the patients due to economic constraints. Even compliance to transfusion is often not optimal. 5 Therefore, there is a possibility that our patients may develop some form of derangement in glucose metabolism at an earlier age.E beta thalassemia is a common variety of thalassemia found in Eastern part of India, besides beta-thalassemia major; but no study is available regarding glucose metabolism status in them.Keeping these in mind, we planned our study to evaluate the status of glucose metabolism in terms of incidence of diabetes, impaired glucose tolerance and parameters related to insulin resistance in thalassemia patients (both beta thalassemia major and E beta thalassemia) who do not receive chelation therapy.
MATERIALS & METHODS

Thalassemia patients attending Burdwan Medical
College and Hospital and College of Medical Sciences
Bharatpur for treatment were included in this study. 
RESULTS
In our study no one from any group had qualified to be labeled as suffering from diabetes mellitus (DM) or having impaired glucose tolerance.
Fasting serum insulin, insulin resistance and beta cell function (%B) all were significantly higher in group 1, when compared to group 2 and group 3. Insulin sensitivity (%S) was significantly lower in group 1, compared to other groups. No significant difference was noted between groups 2 and 3 in any of these parameters [ Table 1 ]. is p value when groups 1 and 2 are compared for significance, p [1] [2] [3] between groups 1 and 3 and p [2] [3] between groups 2 and 3.
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DISCUSSION
Result of our study reflects the ground reality of condition of most of the thalassemic patients in developing countries including ours where iron chelation therapy is suboptimal or not done at all. Regular blood transfusion is also not done in some cases. This is reflected by very high serum ferritin levels in them.
In our study no one among the cases or controls had Diabetes Mellitus(DM) or Impaired Glucose Tolerance(IGT). The reported incidence of impaired glucose tolerance and diabetes mellitus vary from 0-19.5% (4-11) to 0-24% respectively in different studies. [4] [5] [7] [8] [9] [10] [11] Though diabetes has been observed as early as 5.5 years
5
, but mean age of onset of DM and IGT is late adolescence onwards, as found in different studies. 9, 12 Findings of various studies are given in Table   In group 1, FSI and IR showed positive correlation with some parameters related to iron overload like total amount of packed cells received, serum ferritin and spleen size. %S showed negative correlation with these parameters. %B, though, was significantly higher among patients of group 1; it didnot show any correlation with these parameters [ Table 2 ]. In our study, insulin Sensitivity in cases was found to be significantly lower than the controls (p value 0.001) by independent t test. Some workers have found similar results 19, 21 . %S correlates negatively with total amount of packed cells received, spleen size and serum ferritin. As we know insulin sensitivity is the reverse of insulin resistance, this finding is expected.
On the other hand, we found beta cell function to be significantly higher in cases than controls. There is dearth of literature regarding beta cell function. Jaruratanasirikul Chelation therapy should be started in all thalassemia patients so that iron overload related problems can be retarded. 
